TWO NOVEL FLAVONE C-GLYCOSIDES ISOLATED FROM AFROCARPUS GRACILIOR: POM ANALYSES AND IN VITRO CYTOTOXIC ACTIVITY AGANIST HEPATOCELLULAR CARCINOMA
Objective: Cancer is considered as one of the top reasons of death and the number of cases increasing gradually. Cancer is severe clinical difficulty to the health caution system. This study explored two novel polyphenols of Afrocarpus gracilior Pilger growing in Egypt and evaluated their cytotoxic activity.
Methods: Methanolic (80%) extract of the leaves of A. gracilior was subjected to column chromatography; the chemical structures of the isolated compounds were established by advanced spectral techniques: UV, 1H, 13C NMR, two dimensional NMR (2D NMR) and electron spray ionization mass spectroscopy (ESI-MS). Compounds 1 and 2 were studied for their cytotoxic activity against hepatocellular carcinoma (Hep-G2) using sulforhodamine B (SRB) assay. Furthermore the pharmacokinetics profiles of these molecules were accessed by employing Petra/Osiris/Molinspiration (POM) analyses.
Results: Two novel C-flavonoid glycosides were isolated [1: Apigenin 8-C-β-D-glucopyranosyl-(1```→4``)-O-β-D-glucopyranoside] and [2: 7-O methyl-luteolin 8-C-β-glucopyranosyl-(1```→4``)-O-β-D-glucopyranoside]. They exhibited significant cytotoxic activity (IC50 = 9.02 and 15.61 µg/ml, respectively) against Hep-G2 cells. The POM analyses revealed that the activity of these two compounds depends on the presence of glucosyl and alkyl groups at the internal and terminal atmosphere of the compounds.
Conclusion: These findings demonstrated that the leaves of A. gracilior contain a series of bioactive polyphenolic compounds with significant cytotoxic properties against hepatocellular carcinoma and may be used as alternative anticancer agents for doxorubicin. On the basis of POM calculations, it will be interesting to develop some alternative flavones because the deglucosylated derivatives have a better drug score than parent molecules. This preliminary study will be extended to other strains of cancer.
2. Kakrani PH, Kakrani HN, Raval M. Cytotoxic effect of Corchorus depressus against HepG2 and HLE human liver cancer cells. Asian J Pharm Clin Res 2018;11:187-9.
3. Rocken C, Carl-McGrath S. Pathology and pathogenesis of hepatocellular carcinoma. Dig Dis 2001;19:269–78.
4. Ohata K, Hamasaki K, Toriyama K, Ishikawa H, Nakao K, Eguchi K. High viral load is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis B virus infection. J Gastroen Hepatol 2004;19:670-5.
5. Kapadia GJ, Azuine MA, Takayasu J, Konoshima T, Takasaki M, Nishino H, et al. Inhibition of epstein-barr virus early antigen activation promoted by 12-O-tetradecanoylphorbol-13-acetate by the non-steroidal anti-inflammatory drugs. Cancer Lett 2000;161:221-9.
6. Thomas MB, Zhu AX. Hepatocellular carcinoma the need for progress. J Clin Oncol 2005;23:2892-9.
7. Saetung A, Itharat A, Dechsukum C, Wattanapiromsakul C, Keawpradub K, Ratanasuwan P. Cytotoxic activity of Thai medicinal plants for cancer treatment. J Sci Technol 2005;27:469-78.
8. Rajkapoor B, Sankari M, Sumithra M, Anbu J, Harikrishnan N, Gobinath M, et al. Antitumor and cytotoxic effects of Phyllanthus polyphyllus on Ehrlich ascites carcinoma and human cancer cell lines. Biosci Biotechnol Biochem 2007;71:2177-83.
9. Ntsoelinyane PH, Mashele SS, Manduna IT. The anticancer, antioxidant and phytochemical screening of Philenoptera violacea and Xanthocercis zambesiaca leaf, flower and twig extracts. Int J Pharmacol Res 2014;4:100-5.
10. Hsu HF, Houng JY, Chang CL, Wu CC, Chang FR, Wu YC. Antioxidant activity, cytotoxicity and DNA information of Glossogyne tenuifolia. J Agric Food Chem 2005;53:6117-25.
11. Marzouk MS, Moharram FA, Haggag EG, Ibrahim MT, Badary OA. Antioxidant flavonol glycosides from Schinus molle. Phytother Res 2006;20:200-5.
12. Prasad KN, Hao J, Yi C, Zhang D, Qiu S, Jiang Y, et al. Antioxidant and anticancer activities of wampee (Clausena lansium (Lour.) Skeels) peel. J Biomed Biotechnol 2009;30:1-6.
13. Ayoub NA. A trimethoxyellagic acid glucuronide from Conocarpus erectus leaves: Isolation, characterization and assay of antioxidant capacity. Pharm Biol 2010;48:328-32.
14. Ding F, Peng W. Biological activity of natural flavonoids as impacted by protein flexibility: an example of flavanones. Mol Biosyst 2015;11:1119-33.
15. Woldemichael GM, Franzblau SG, Zhang F, Wang Y, Timmermann BN. Inhibitory effect of sterols from Ruprechtia triflora and diterpenes from Calceolaria pinnifolia on the growth of Mycobacterium tuberculosis. Planta Med 2003;69:628-31.
16. Abdillahi HS, Stafford GI, Finnie JF, Van Staden J. Antimicrobial activity of South African Podocarpus species. J Ethnopharmacol 2008;119:191-4.
17. Carpinella MC, Andrione DG, Ruiz G, Palacios SM. Screening for acetylcholinesterase inhibitory activity in plant extracts from Argentina. Phytother Res 2010;24:259-63.
18. Abdillahi HS, Finnie JF, Van Staden J. Anti-inflammatory, antioxidant, anti-tyrosinase and phenolic contents of four Podocarpus species used in traditional medicine in South Africa. J Ethnopharmacol 2011;136:496-503.
19. Abreu MB, Temraz A, Malafronte N, Mujica FG, Duque S, Braca A. Phenolic derivatives from Ruprechtia polystachya and their inhibitory activities on the glucose-6-phosphatase system. Chem Biodivers 2011;8:2126-34.
20. Kamal AM, Abdelhady MIS, Elmorsy EM, Mady MS, Abdelkhalik SM. Phytochemical and biological investigation of leaf extracts of Podocarpus gracilior and Ruprechtia polystachya resulted in isolation of novel polyphenolic compound. Life Sci 2012; 9:1126-35.
21. Stahlhut R, Park G, Petersen R, Ma W, Hylands P. The occurrence of the anti-cancer diterpene taxol in Podocarpus gracilior pilger (Podocarpaceae). Biochem Syst Ecol 1999;27:613-22.
22. Farjon A. Afrocarpus gracilior. The IUCN Red List Threatened Species; 2013.
23. Stahl E. Thin layer chromatography. 2nd ed. Springer Verlag, Berlin, Heidelberg, New York; 1969.
24. Mabry TJ, Markham KR, Thomas MB. The systematic identification of flavonoids, Springer Verlag. New York; 1970. p. 4-35.
25. Brasseur T, Angenot L. Le melange diphenylborate daminoethanol-PEG 400. Un interessant reactif de revelation des flavonoides. J Chromatogr 1986;351:351-5.
26. Hansen MB, Nielsen SE, Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 1985;119:203-10.
27. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990;82:1107-12.
28. Marzouk MS, Moharram FA, El-Dib RA, El-Shenawy SM, Tawfike AF. Polyphenolic profile and bioactivity study of Oenothera speciosa Nutt. aerial parts. Molecules 2009;14:1456-67.
29. Harborne JB, Mabry TJ. The flavonoids: advances in research. In: Markham KR, Mohanchari V. eds. Carbon-13 NMR spectroscopy of flavonoids. London: Chapman and Hall, University Press: Cambridge; 1982. p. 119-32.
30. Agrawal PK. Studies in organic chemistry 39, 13C NMR of flavonoids. In: Agrawal PK, Bansal MC. eds. Flavonoid Glycosides. New York: Elsevier Science; 1989. p. 283-364.
31. Harborne JB. The flavonoids: advances in research since 1986. In: Williams CA, Harborne JB. eds. Flavone and Flavonol Glycoside; London: Chapman and Hall, Ltd, University Press Cambridge; 1994. p. 337–85.
32. Vazquez E, Martinez EM, Cogordan JA, Delgado G. Triterpenes, phenols, and other constituents from the leaves of Ochroma pyramidala (Balsa wood, Bombacaceae). Preferred confirmations of 8-C-?-D-glucopyranosyl-apigenin (Vitexin). Rev Soc Quim Mex 2001;45:254-8.
33. Kim I, Chin Y, Lim SW, Kim YC, Kim J. Norisoprenoids and hepatoprotective flavones glycosides from the aerial parts of Beta vulgaris var. Cicla Arch Pharm Res 2004;27:600-3.
34. Upur H, Amat N, Blazekovic B, Talip A. Protective effect of Cichorium glandulosum root extract on carbon tetrachloride-induced and galactosamine-induced hepatotoxicity in mice. Food Chem Toxicol 2009;47:2022-30.
35. Nawwar MAM, El-Sissi HI, Barakat HH. Flavonoid constituents of Ephedra alata. Phytochemistry 1984;23:2937-9.
36. Pastene ER, Bocaz G, Peric I, Montes M, Silva V, Riffo E. Separation by capillary electrophoresis of C-glycosylflavonoids in Passiflora sp. extracts. Bol Soc Chil Quim 2000;45:461-7.
37. Li H, Zhou P, Yang Q, Shen Y, Deng J, Li L, et al. Comparative studies on anxiolytic activities and flavonoid compositions of Passiflora edulis 'edulis' and Passiflora edulis 'flavicarpa'. J Ethnopharmacol 2011;133:1085-90.
38. Boyd MR. The NCI in vitro anticancer drug discovery screen: concept, implementation and operation (1985–1995). In: Teicher BA. ed. Anticancer Drug; 1997.
39. Takaki Doi S, Hashimoto K, Yamamura M, Kamei C. Antihypertensive activities of royal jelly protein hydrolysate and its fractions in spontaneously hypertensive rats. Acta Med Okayama 2009;63:57-64.
40. Silici S, Ekmekcioglu O, Kanbur M, Deniz K. The protective effect of royal jelly against cisplatin-induced renal oxidative stress in rats. World J Urol 2011;29:127-32.
41. Note1. Wikipedia, Doxorubicin; 2015. http://en.wikipedia.org/ wiki/Doxorubicin [Last accessed on 10 Feb 2019].
This work is licensed under a Creative Commons Attribution 4.0 International License.